Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance accuracy, reproducibility, and efficiency in cell manufacturing. Astellas ...

NORTHBROOK, Ill., Feb. 27, 2025 /PRNewswire/ -- Astellas Pharma U.S. Inc. (Head of Commercial: Mike Petroutsas, "Astellas"), and MBC BioLabs, a premier launchpad for ...

MOSCOW, March 11 - Ukraine on Tuesday launched its biggest ever drone attack on Moscow and the surrounding region, killing at least three employees of a meat warehouse, injuring 17 others and ...

The assault, which the mayor called the largest on Russia’s capital since the war began, was a reminder of Ukraine’s power to strike as its president proposes an air truce. By Marc Santora and ...

(RTTNews) - Japan's Astellas Pharma Inc. (ALPMY, ALPMY) announced that it has signed a definitive agreement with YASKAWA Electric Corp. to establish a joint venture for the development of a cell ...

"As a multinational pharmaceutical company, Astellas has benefited from these supportive policies in its business growth in China, and we remain confident in the country's continuous endeavors to ...

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

At least three people have been killed — two in Moscow and one in the Donetsk region — and multiple injured as Russia and Ukraine traded fire ahead of talks on ending the war in Saudi Arabia.

In a report released on March 5, Seiji Wakao from J.P. Morgan maintained a Hold rating on Astellas Pharma (ALPMF – Research Report), with a price target of Yen1,700.00. The company’s shares ...

Moscow’s defense ministry said it had downed 343 drones it claimed Ukraine had fired at Russia, of which 91 had targeted the Moscow region. It also said six Ukrainian strike drones were ...

Astellas has licensed rights to a drug developed by Selecta Biosciences that could make more patients eligible for treatment with its gene therapy for inherited neuromuscular disorder Pompe disease.